Select Committee · Science and Technology Committee (Commons)

Antimicrobial resistance (AMR)

Status: Closed Opened: 11 Sep 2013 Closed: 21 Oct 2014 1 report

Inquiry scope

Government response to the House of Commons Science and Technology Committee report: Ensuring access to working antimicrobials (PDF 458.93 KB) The World Health Organization (WHO) defines antimicrobial resistance (AMR) as resistance of a microorganism to an antimicrobial medicine to which it was originally sensitive. Resistant organisms (including bacteria, fungi, viruses and some parasites) are able to withstand antimicrobial medicines (such as antibiotics, antifungals, antivirals, and antimalarials) so that standard treatments become ineffective and infections persist, increasing the risk of spread to others. The development of AMR is a natural phenomenon but certain human actions accelerate the emergence and spread of AMR. The scale of the threat of antimicrobial resistance (AMR) and the case for action was set out in the Annual Report of the Chief Medical Officer 2011, published in March 2013. The Government’s UK Five Year Antimicrobial Resistance Strategy 2013 to 2018 sets out actions to address the problem of AMR.

Reports

1 report

1st Report - Ensuring access to working antimicrobials

HC No.: HC 509
Published: 7 Jul 2014
Items: 0
Response: Response document linked: 3rd Special Report - Ensuring access to work… Read government response ↗

Oral evidence sessions

5 sessions

On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.

Date	Session and witnesses	Source
12 Mar 2014	Oral evidence session No witnesses recorded	View ↗
26 Feb 2014	Oral evidence session No witnesses recorded	View ↗
29 Jan 2014	Oral evidence session No witnesses recorded	View ↗
8 Jan 2014	Oral evidence session No witnesses recorded	View ↗
18 Dec 2013	Oral evidence session No witnesses recorded	View ↗